相关实验视频
Updated: Jul 26, 2026

10:49
Planar and Three-Dimensional Printing of Conductive Inks
Published on: December 9, 2011
37.2K
纳米颗粒的二维打印作为个性化药物管理的有前途的治疗方法
1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Pharmaceutical development and technology
|October 3, 2023
概括
2D打印提供了个性化的药物解决方案,通过实现精确的药物沉积和多种药物产品. 进入市场必须解决稳定性的挑战.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
背景情况:
- 人们越来越认识到基因对个体生理学和新陈代谢的影响,因此需要个性化的患者治疗.
- 目前针对个性化医疗的现有方法尚未得到充分实施,这凸显了当前制药制造业存在的差距.
- 药品的大批量生产在满足不同个体患者需求方面存在缺点.
研究的目的:
- 探索2D打印技术作为个性化药物解决方案的潜力.
- 突出2D打印在传统散装制药制造上的优势.
- 确定2D打印药物的医药市场整合需要克服的挑战.
主要方法:
- 对各种用于制药应用的2D打印技术的审查.
- 在2D打印过程中纳米技术原理的整合.
- 分析与2D打印药品相关的好处和挑战.
主要成果:
- 2D打印使准确的,按需的药物沉积和多种药物的组合在单个剂量形式中成为可能.
- 纳米技术的整合增强了药物输送的控制,刺激响应,和有针对性的释放.
- 关键的好处包括可调节的药物度和克服批量制造的局限性.
结论:
- 2D打印,特别是纳米技术,为个性化药物提供了一个有前途的途径,提供量身定制的药物度和释放配置文件.
- 解决化学,物理和微生物稳定性问题对于成功商业化2D打印药品至关重要.
- 这项技术有可能满足个体治疗需求,克服当前大规模制药生产的缺点.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

